<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="interaction" /><meta name="keywords" content="" /><title>Carbamazepine: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="bnf_int277-carbamazepine.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="bnf_int277-carbamazepine.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=bnf_int277-carbamazepine.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP8848-interactions.htm">Appendix 1 Interactions</a> &gt; <a href="PHP8852-list-of-drug-interactions.htm">List of drug interactions</a> &gt; <a href="bnf_int276-antiepileptics.htm">Antiepileptics</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="bnf_int1040-zonisamide.htm" title="Previous: Zonisamide">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="bnf_int281-ethosuximide.htm" title="Next: Ethosuximide">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Carbamazepine</h1><?highlighter on?><div id="pC" class="jN"><p><strong>Carbamazepine</strong> has the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int551-acetazolamide.htm">Acetazolamide</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>increased by</span> <span>acetazolamide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int20-alcohol.htm">Alcohol</a></td><td><p><span>CNS side-effects of </span> <span>carbamazepine</span> <span>possibly increased by</span> <span>alcohol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int241-antidepressants-tricyclic.htm">Antidepressants, Tricyclic</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>tricyclics</span> <span>(reduced plasma concentration and reduced effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1010-aprepitant.htm">Aprepitant</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>aprepitant</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1011-aripiprazole.htm">Aripiprazole</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>aripiprazole</span> <span>—increase dose of <span>aripiprazole</span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1214-boceprevir.htm">Boceprevir</a></td><td class="cAI"><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>boceprevir</span> <span>(plasma concentration of <span>boceprevir</span> possibly reduced)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int896-bupropion.htm">Bupropion</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>bupropion</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1204-cabazitaxel.htm">Cabazitaxel</a></td><td class="cAI"><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>cabazitaxel</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int469-calcium-channel-blockers-dihydropyridines.htm">Calcium-channel Blockers (dihydropyridines)</a></td><td><p><span></span> <span>carbamazepine</span> <span>probably reduces effects of</span> <span>dihydropyridines</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int947-caspofungin.htm">Caspofungin</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>caspofungin</span> <span>—consider increasing dose of <span>caspofungin</span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int499-ciclosporin.htm">Ciclosporin</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>ciclosporin</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int744-cimetidine.htm">Cimetidine</a></td><td class="cAI"><p><span>metabolism of </span> <span>carbamazepine</span> <span>inhibited by</span> <span>cimetidine</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int168-clarithromycin.htm">Clarithromycin</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>increased by</span> <span>clarithromycin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int408-clonazepam.htm">Clonazepam</a></td><td><p><span></span> <span>carbamazepine</span> <span>often reduces plasma concentration of</span> <span>clonazepam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int865-clopidogrel.htm">Clopidogrel</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>possibly reduces antiplatelet effect of</span> <span>clopidogrel</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int364-clozapine.htm">Clozapine</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>clozapine</span> <span>(reduced plasma concentration), also avoid concomitant use of drugs with substantial potential for causing agranulocytosis</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Avoid concomitant use of clozapine with drugs that have a substantial potential for causing agranulocytosis</p></div></td></tr><tr><td><a href="bnf_int484-corticosteroids.htm">Corticosteroids</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>corticosteroids</span> <span>(reduced effect)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</p></div></td></tr><tr><td><a href="bnf_int220-coumarins.htm">Coumarins</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>coumarins</span> <span>(reduced anticoagulant effect)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Change in patient's clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</p></div></td></tr><tr><td><a href="bnf_int1120-dabigatran-etexilate.htm">Dabigatran Etexilate</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>dabigatran etexilate</span> <span>—manufacturer of <span>dabigatran etexilate</span> advises avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int579-danazol.htm">Danazol</a></td><td class="cAI"><p><span>metabolism of </span> <span>carbamazepine</span> <span>inhibited by</span> <span>danazol</span> <span>(increased risk of toxicity)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1091-darunavir.htm">Darunavir</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>darunavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int90-dextropropoxyphene.htm">Dextropropoxyphene</a></td><td class="cAI"><p><span>effects of </span> <span>carbamazepine</span> <span>enhanced by</span> <span>dextropropoxyphene</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int468-diltiazem.htm">Diltiazem</a></td><td class="cAI"><p><span>effects of </span> <span>carbamazepine</span> <span>enhanced by</span> <span>diltiazem</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int524-diuretics.htm">Diuretics</a></td><td><p><span>increased risk of hyponatraemia when </span> <span>carbamazepine</span> <span>given with</span> <span>diuretics</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int212-doxycycline.htm">Doxycycline</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>doxycycline</span> <span>(reduced effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1176-dronedarone.htm">Dronedarone</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>dronedarone</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int874-efavirenz.htm">Efavirenz</a></td><td><p><span>plasma concentration of both drugs reduced when </span> <span>carbamazepine</span> <span>given with</span> <span>efavirenz</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1025-eplerenone.htm">Eplerenone</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>eplerenone</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1205-eribulin.htm">Eribulin</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>eribulin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int169-erythromycin.htm">Erythromycin</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>increased by</span> <span>erythromycin</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to small amounts of erythromycin used topically</p></div></td></tr><tr><td><a href="bnf_int1153-eslicarbazepine.htm">Eslicarbazepine</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>eslicarbazepine</span> <span>but risk of side-effects increased</span>  </p></td><td></td></tr><tr><td><a href="bnf_int281-ethosuximide.htm">Ethosuximide</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>ethosuximide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1135-etravirine.htm">Etravirine</a></td><td><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>etravirine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int471-felodipine.htm">Felodipine</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces effects of</span> <span>felodipine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int301-fluconazole.htm">Fluconazole</a></td><td><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>possibly increased by</span> <span>fluconazole</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> In general, fluconazole interactions relate to multiple-dose treatment</p></div></td></tr><tr><td><a href="bnf_int234-fluoxetine.htm">Fluoxetine</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>increased by</span> <span>fluoxetine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int235-fluvoxamine.htm">Fluvoxamine</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>increased by</span> <span>fluvoxamine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1019-fosamprenavir.htm">Fosamprenavir</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>fosamprenavir</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Fosamprenavir is a prodrug of amprenavir</p></div></td></tr><tr><td><a href="bnf_int1170-gefitinib.htm">Gefitinib</a></td><td><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>gefitinib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int387-haloperidol.htm">Haloperidol</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>haloperidol</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int933-imatinib.htm">Imatinib</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>imatinib</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int398-indinavir.htm">Indinavir</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>indinavir</span> <span>, also plasma concentration of <span>carbamazepine</span> possibly increased</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1006-irinotecan.htm">Irinotecan</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>irinotecan</span> <span>and its active metabolite</span>  </p></td><td></td></tr><tr><td><a href="bnf_int165-isoniazid.htm">Isoniazid</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>increased by</span> <span>isoniazid</span> <span>(also possibly increased <span>isoniazid</span> hepatotoxicity)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int684-isotretinoin.htm">Isotretinoin</a></td><td><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>possibly reduced by</span> <span>isotretinoin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int472-isradipine.htm">Isradipine</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces effects of</span> <span>isradipine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>itraconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>possibly increased by</span> <span>ketoconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int283-lamotrigine.htm">Lamotrigine</a></td><td><p><span></span> <span>carbamazepine</span> <span>often reduces plasma concentration of</span> <span>lamotrigine</span> <span>, also plasma concentration of an active metabolite of <span>carbamazepine</span> sometimes raised (but evidence is conflicting)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1128-lapatinib.htm">Lapatinib</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>lapatinib</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int913-levetiracetam.htm">Levetiracetam</a></td><td><p><span>possible increased risk of </span> <span>carbamazepine</span> <span>toxicity when given with</span> <span>levetiracetam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int372-lithium.htm">Lithium</a></td><td><p><span>neurotoxicity may occur when </span> <span>carbamazepine</span> <span>given with</span> <span>lithium</span> <span>without increased plasma concentration of <span>lithium</span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int922-lopinavir.htm">Lopinavir</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>lopinavir</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> In combination with ritonavir as Kaletra® (ritonavir is present to inhibit lopinavir metabolism and increase plasma-lopinavir concentration)—see also Ritonavir</p></div></td></tr><tr><td><a href="bnf_int257-maois.htm">MAOIs</a></td><td class="cAI"><p><span>manufacturer of </span> <span>carbamazepine</span> <span>advises avoid for 2 weeks after stopping</span> <span>MAOIs</span> <span>, also antagonism of anticonvulsant effect</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> For interactions of reversible MAO-A inhibitors (RIMAs) see Moclobemide, and for interactions of MAO-B inhibitors see Rasagiline and Selegiline; the antibacterial Linezolid is a reversible, non-selective MAO inhibitor</p></div></td></tr><tr><td><a href="bnf_int97-methadone.htm">Methadone</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>methadone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int254-mianserin.htm">Mianserin</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>mianserin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int299-miconazole.htm">Miconazole</a></td><td><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>possibly increased by</span> <span>miconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int421-midazolam.htm">Midazolam</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>midazolam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int823-mirtazapine.htm">Mirtazapine</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>mirtazapine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int620-muscle-relaxants-non-depolarising.htm">Muscle Relaxants, non-depolarising</a></td><td><p><span></span> <span>carbamazepine</span> <span>antagonises muscle relaxant effect of</span> <span>non-depolarising muscle relaxants</span> <span>(accelerated recovery from neuromuscular blockade)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int842-nelfinavir.htm">Nelfinavir</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>nelfinavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int843-nevirapine.htm">Nevirapine</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>nevirapine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int474-nicardipine.htm">Nicardipine</a></td><td><p><span></span> <span>carbamazepine</span> <span>probably reduces effects of</span> <span>nicardipine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int475-nifedipine.htm">Nifedipine</a></td><td><p><span></span> <span>carbamazepine</span> <span>probably reduces effects of</span> <span>nifedipine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int476-nimodipine.htm">Nimodipine</a></td><td><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>nimodipine</span> <span>(plasma concentration of <span>nimodipine</span> possibly reduced)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int636-oestrogens.htm">Oestrogens</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>oestrogens</span> <span>(reduced contraceptive effect—see <a title="target-block: COCs interactions" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a>)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a></p></div></td></tr><tr><td><a href="bnf_int366-olanzapine.htm">Olanzapine</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>olanzapine</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1045-ondansetron.htm">Ondansetron</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>ondansetron</span> <span>(reduced effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int900-oxcarbazepine.htm">Oxcarbazepine</a></td><td><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>sometimes reduced by</span> <span>oxcarbazepine</span> <span>(but concentration of an active metabolite of <span>carbamazepine</span> may be increased), also plasma concentration of an active metabolite of <span>oxcarbazepine</span> often reduced</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1101-paliperidone.htm">Paliperidone</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>paliperidone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int59-paracetamol.htm">Paracetamol</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly accelerates metabolism of</span> <span>paracetamol</span> <span>(also isolated reports of hepatotoxicity)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int437-phenobarbital.htm">Phenobarbital</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly increases plasma concentration of</span> <span>phenobarbital</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int284-phenytoin.htm">Phenytoin</a></td><td><p><span>plasma concentration of both drugs often reduced when </span> <span>carbamazepine</span> <span>given with</span> <span>phenytoin</span> <span>, also plasma concentration of <span>phenytoin</span> may be increased</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1060-posaconazole.htm">Posaconazole</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>posaconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int664-progestogens.htm">Progestogens</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>progestogens</span> <span>(reduced contraceptive effect—see <a title="target-block: COCs interactions" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a>)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a>. For further information on interactions of oral progestogen-only contraceptives, see also <a href="PHP4944-oral-progestogen-only-contraceptives.htm#PHP4945">section 7.3.2.1</a>; parenteral progestogen-only contraceptives, see also <a href="PHP4960-parenteral-progestogen-only-contraceptives.htm#PHP4965">section 7.3.2.2</a>; the intra-uterine progestogen-only device, see also <a href="PHP4973-intra-uterine-progestogen-only-device.htm#PHP4974">section 7.3.2.3</a>; hormonal emergency contraception, see also <a href="PHP5019-hormonal-methods.htm#PHP5024">section 7.3.5</a></p></div></td></tr><tr><td><a href="bnf_int824-quetiapine.htm">Quetiapine</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>quetiapine</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int231-reboxetine.htm">Reboxetine</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>reboxetine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1195-retigabine.htm">Retigabine</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>retigabine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int200-rifabutin.htm">Rifabutin</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>reduced by</span> <span>rifabutin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1225-rilpivirine.htm">Rilpivirine</a></td><td class="cAI"><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>rilpivirine</span> <span>(plasma concentration of <span>rilpivirine</span> possibly reduced)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int368-risperidone.htm">Risperidone</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>risperidone</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>possibly increased by</span> <span>ritonavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1102-rufinamide.htm">Rufinamide</a></td><td><p><span>plasma concentration of both drugs possibly reduced when </span> <span>carbamazepine</span> <span>given with</span> <span>rufinamide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int791-saquinavir.htm">Saquinavir</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>saquinavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int605-simvastatin.htm">Simvastatin</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>simvastatin</span> <span>—consider increasing dose of <span>simvastatin</span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1144-stiripentol.htm">Stiripentol</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>carbamazepine</span> <span>increased by</span> <span>stiripentol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1216-telaprevir.htm">Telaprevir</a></td><td class="cAI"><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>telaprevir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int946-telithromycin.htm">Telithromycin</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>telithromycin</span> <span>(avoid during and for 2 weeks after <span>carbamazepine</span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int734-theophylline.htm">Theophylline</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>theophylline</span> <span>(reduced effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int935-thyroid-hormones.htm">Thyroid Hormones</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>thyroid hormones</span> <span>(may increase requirements for <span>thyroid hormones</span> in hypothyroidism)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int857-tiagabine.htm">Tiagabine</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>tiagabine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int737-tibolone.htm">Tibolone</a></td><td><p><span></span> <span>carbamazepine</span> <span>accelerates metabolism of</span> <span>tibolone</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1203-ticagrelor.htm">Ticagrelor</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>ticagrelor</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1055-tipranavir.htm">Tipranavir</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>tipranavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int285-topiramate.htm">Topiramate</a></td><td><p><span></span> <span>carbamazepine</span> <span>often reduces plasma concentration of</span> <span>topiramate</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int582-toremifene.htm">Toremifene</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly accelerates metabolism of</span> <span>toremifene</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int106-tramadol.htm">Tramadol</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces effects of</span> <span>tramadol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int255-trazodone.htm">Trazodone</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>trazodone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1163-ulipristal.htm">Ulipristal</a></td><td class="cAI"><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>ulipristal</span> <span>(contraceptive effect of <span>ulipristal</span> possibly reduced)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int286-valproate.htm">Valproate</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>valproate</span> <span>, also plasma concentration of active metabolite of <span>carbamazepine</span> increased</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1227-vandetanib.htm">Vandetanib</a></td><td><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>vandetanib</span> <span>(plasma concentration of <span>vandetanib</span> possibly reduced)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1229-vemurafenib.htm">Vemurafenib</a></td><td><p><span>avoidance of </span> <span>carbamazepine</span> <span>advised by manufacturer of</span> <span>vemurafenib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int467-verapamil.htm">Verapamil</a></td><td class="cAI"><p><span>effects of </span> <span>carbamazepine</span> <span>enhanced by</span> <span>verapamil</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int768-vitamin-d.htm">Vitamin D</a></td><td><p><span></span> <span>carbamazepine</span> <span>possibly increases requirements for</span> <span>vitamin D</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int948-voriconazole.htm">Voriconazole</a></td><td class="cAI"><p><span></span> <span>carbamazepine</span> <span>possibly reduces plasma concentration of</span> <span>voriconazole</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1040-zonisamide.htm">Zonisamide</a></td><td><p><span></span> <span>carbamazepine</span> <span>reduces plasma concentration of</span> <span>zonisamide</span> <span></span>  </p></td><td></td></tr></tbody></table><p><strong>Carbamazepine</strong> belongs to <strong>Antiepileptics</strong> and will have the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int232-antidepressants-ssri.htm">Antidepressants, SSRI</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>SSRIs</span> <span>(convulsive threshold lowered)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int241-antidepressants-tricyclic.htm">Antidepressants, Tricyclic</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>tricyclics</span> <span>(convulsive threshold lowered)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int252-antidepressants-tricyclic-related.htm">Antidepressants, Tricyclic (related)</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>possibly antagonised by</span> <span>tricyclic-related antidepressants</span> <span>(convulsive threshold lowered)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int363-antipsychotics.htm">Antipsychotics</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>antipsychotics</span> <span>(convulsive threshold lowered)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Increased risk of toxicity with myelosuppressive drugs</p></div></td></tr><tr><td><a href="bnf_int257-maois.htm">MAOIs</a></td><td><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>possibly antagonised by</span> <span>MAOIs</span> <span>(convulsive threshold lowered)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> For interactions of reversible MAO-A inhibitors (RIMAs) see Moclobemide, and for interactions of MAO-B inhibitors see Rasagiline and Selegiline; the antibacterial Linezolid is a reversible, non-selective MAO inhibitor</p></div></td></tr><tr><td><a href="bnf_int337-mefloquine.htm">Mefloquine</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>mefloquine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int856-orlistat.htm">Orlistat</a></td><td class="cAI"><p><span>possible increased risk of convulsions when </span> <span>antiepileptics</span> <span>given with</span> <span>orlistat</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int905-st-johns-wort.htm">St John's Wort</a></td><td class="cAI"><p><span>avoid concomitant use of </span> <span>antiepileptics</span> <span>with</span> <span>St John's wort</span> <span></span>  </p></td><td></td></tr></tbody></table></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="bnf_int1040-zonisamide.htm">Previous: Zonisamide</a> | <a class="top" href="bnf_int277-carbamazepine.htm#">Top</a> | <a accesskey="]" href="bnf_int281-ethosuximide.htm">Next: Ethosuximide</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>